Part,  Chapter, Paragraph

 1    I,     2. 10.  1|        populations based on their genomic risk profile. The upcoming
 2    I,     2. 10.  1|       factors of diseases such as genomic variants. The occurrence
 3    I,     2. 10.  1|           can only be used if the genomic risk stratification shows
 4    I,     2. 10.  1|           based on the individual genomic profile.~So far healthcare
 5  III,    10.  2.  4|        populations based on their genomic risk profile (Lunshof et
 6  III,    10.  2.  4|       factors of diseases such as genomic variants. Nonetheless, the
 7  III,    10.  2.  4|           can only be used if the genomic risk stratification shows
 8  III,    10.  2.  4|       mutations at the functional genomic unit level, and to better
 9  III,    10.  2.  4|      entities;~· the concept of a genomic variant being in individuals
10  III,    10.  2.  4|           potential of individual genomic profiling: i.e., the concurrent
11  III,    10.  2.  4|  concurrent detection of multiple genomic variants that have been
12  III,    10.  2.  4| individual genotype status on all genomic variants increases or decreases
13  III,    10.  2.  4|     screening based on individual genomic profiling;~· the impact
14  III,    10.  2.  4|        drug targets~· the role of genomic determinants not only within
15  III,    10.  2.  4|           obesity);~· the role of genomic determinants as “necessary
16  III,    10.  2.  4|           from “genetic test” to “genomic variant” to “genome-based
17  III,    10.  2.  4|       possible to assess multiple genomic and protein differences
18  III,    10.  2.  4|         deriving from statistics, genomic research, the family history,
19  III,    10.  2.  4|        family history, individual genomic variants and the individual
20  III,    10.  2.  4|      incomplete and misleading if genomic knowledge is excluded.~ ~
21  III,    10.  2.  4|         risks based on individual genomic profiling and may then implement
22  III,    10.  2.  4|        surveillance, the upcoming genomic knowledge may require fundamental
23  III,    10.  2.  4|       Donnell CJ (2004): Emerging Genomic Technologies and Analytic